Protomer Technologies

In a deal that may bring Eli Lilly and Company an oral alternative to blockbuster Taltz (ixekizumab) for psoriasis, the Indianapolis pharma unveiled an agreement on 20 June to acquire DICE Therapeu

Roche Holding AG , Genentech, Inc. and their affiliated companies were the busiest deal makers in the biopharmaceutical sector for the second consecutive year in 2021, with 23 deals across all cate

Eli Lilly and Company is counting on five key near-term approvals for organic growth, and offered investors a deep dive into those programs during a 15 December financial guidance and R&D overview, a

Looking to add to its already substantial diabetes portfolio, Eli Lilly and Company announced on 14 July that it will buy Protomer Technologies , which is working on glucose-sensitive insulins, les